Insights

Clinical trials increasingly involve participants who speak a wide range of languages. This makes informed consent form translation a critical part of study conduct.   Under 21 CFR Part 50, there are clear regulatory standards for informed consent. When participants aren’t able to understand the consent information presented to them, the ethical foundation of informed consent—and the regulations designed to protect participants—may be compromised. As such, any clinical trials involving participants with limited English proficiency must incorporate informed consent form translation into their workflow.  Errors in translation and failure to document translation practices can lead to audit exposure and issues in clinical trial translation compliance. In this article, we’ll take a closer look at FDA informed consent translation requirements and walk you through some best practices for compliance. Table of Content: Why Informed Consent Form Translation Is a Regulatory Obligation  FDA and IRB Expectations for Translated Informed Consent Forms  Common Audit Risks in ICF Translation  Best Practices for Clinical Trial Translation Compliance  Preparing for Regulatory Inspection  Frequently Asked Questions Conclusion  Clinical trials in the United States must comply with 21 CFR Part 50, which requires that prospective participants receive information in language they can understand before agreeing to participate.  The ethical basis for informed consent is straightforward: Participants must be able to evaluate the risks and benefits of participating in a trial before making their decision. When individuals do not speak English fluently, informed consent form translation enables them to arrive at a well-founded decision about whether or not to participate. Unsurprisingly, studies have shown that insufficient informed consent form translation can be an obstacle to participation for people who don’t speak English. Ultimately, multilingual consent forms make consent meaningful, rather than just procedural.  There are two common approaches to translated informed consent FDA expectations: full translation of the informed consent document or the use of a short-form consent process. The short-form method allows oral presentation of the full consent information with a translated summary document, though it must meet strict ICF translation guidelines.  An institutional review board (IRB) plays a central role in the translation process. Under IRB translation requirements, translated documents must be reviewed and approved to confirm that the translated consent accurately reflects the original text and meets clinical trial translation compliance standards. Maintaining a clear documentation trail, strong version control, and consistent translation practices supports audit readiness during any regulatory inspection.  The FDA informed consent translation requirements and IRB translation requirements establish clear expectations for how translated consent materials ought to be prepared. By meeting the following expectations, you can maintain clinical trial translation compliance and strengthen audit readiness during inspections: 
- Accuracy and completeness: Translations must faithfully reflect the meaning of the original document without omissions, simplifications or added interpretation. For multilingual consent forms in clinical trials, the FDA expects LEP participants to receive the same information—risks, benefits, procedures, rights, etc.—as English-speaking participants. 
- Documentation of translator qualifications: Organizations should maintain records showing that translators are qualified to perform informed consent form translation. This often includes documentation of language proficiency, relevant experience with medical or regulatory texts, and familiarity with informed consent form translation guidelines. 
- Review and approval requirements: The IRB overseeing the study should typically review and approve any translated consent forms before they were used. 
- Certification statements: Studies commonly include a signed certification confirming that the translation is complete and accurate. These statements help create a clear documentation trail which is useful for audits or any other regulatory inspection. 
- Version control requirements: Each translated document should correspond precisely to a specific version of the source informed consent form. Strong version control prevents outdated or inconsistent materials from being used during participant enrollment. 
- IRB submission documentation: When submitting translated materials for review, sponsors or research sites typically provide the translated consent form, the English source document, and supporting translation documentation.  Clinical trials that involve multilingual participants face unique audit risks due to FDA informed consent form translation requirements. Below are a few examples of errors that commonly occur in the ICF translation process that you should be aware of:  To make sure your team is providing LEP participants with thorough informed consent form translations and meeting compliance with FDA and IRB requirements, here are a few best practices you can implement into your translation workflow: 
Work with life sciences-qualified linguists: Working with linguists who specialize in translating and interpreting materials for life sciences organizations ensures that you’re working with people who are familiar with your unique compliance needs. Qualified linguists won’t have to spend time getting up to speed with new procedures or terminology, as they’ve already worked on similar projects. 
Implement dual review process: A second independent linguistic review helps catch terminology issues, omissions, or inconsistencies that might otherwise be missed. Dual review also strengthens the accuracy of multilingual consent forms in clinical trials and supports stronger clinical trial language compliance. 
Maintain traceable documentation: Documentation is critical for audit readiness. Keep an organized record of things like translator qualifications, certification statements, etc., so you have them at the ready during a regulatory inspection. 
Align translation SOPs with sponsor SOPs: Translation procedures should align with the broader standard operating procedures used by sponsors and research sites. This alignment helps ensure that translated informed consent FDA expectations are met consistently across all study documentation 
Maintain version tracking and change logs: Be careful to make sure that you’re translating the most up-to-date version of any and all documentation. 
Archive all translation-related records: Just because you needed a document translated a long time ago, doesn’t mean you should get rid of your records of it. Store old records in an archive that you can come back to in case you need them even after the required retention period is over.  Preparing for a regulatory inspection means making sure your informed consent translation process is clearly documented and that you can show how translated consent forms were produced, reviewed, and maintained.  Inspectors will want to take a close look at the paper trail left during the translation process—they may request the source and target text, records of translator qualifications, signed certifications confirming that a translation is complete, and more. Inspectors will look at these documents to make sure that a qualified linguist was assigned to the task, that the translation fully covers the scope of the source text, and that the translation was adequately reviewed before approval.  Be sure to retain all records related to the informed consent form translation process for the full period required by study and regulatory retention policies—for FDA-regulated clinical trials, investigators must retain records (including documentation showing that informed consent was obtained) for at least two years after either the date the marketing application for the drug/device is approved for the investigated indication, or if no application is filed or approved, two years after the investigation is discontinued and the FDA is notified.  The FDA does not explicitly require “certified translations” for informed consent forms, but it does require translations to be complete and accurate. In practice, organizations usually maintain record of translator qualifications and certification statements to demonstrate compliance with translation requirements during regulatory inspection.  Short-form consent is permitted only when the participant does not speak English and a full translation is not available. Under 21 CFR Part 50, the consent information must still be presented orally in the participant’s language, and the short-form document and English consent form must be reviewed and approved by the IRB.  Sponsors and research sites should keep a detailed record of the translation procedure for at least two years. Such documentation includes translator qualifications, certification statements, review and approval records, and any records showing version control between the English source and translated target versions.  Translations must be updated whenever the English source text is updated to ensure consistency in the information presented to English-speaking participants and LEP participants.  By implementing the best practices laid out in this blog post, researchers can rest easy knowing that all of their trial participants are making well-informed decisions about their involvement. Informed consent form translation helps researchers meet both ethical and regulatory obligations.  Working closely with a language service provider who’s familiar with standard procedures for life sciences organizations is key to audit readiness. At Avantpage Life Sciences, we can translate your informed consent forms into more than 150 different languages, keeping a thorough paper trail at every step of the way. Download our compliance checklist today or contact us to learn more. 

In life sciences, where science speaks every language, translation is never just about words. Every term, phrase, and abbreviation must carry the precise scientific meaning intended by its author, because even the smallest linguistic slip can have serious regulatory or safety consequences. That’s why subject matter experts in life sciences translation play such a crucial role. While linguists ensure linguistic fluency and cultural accuracy, subject matter experts (SMEs) provide deep scientific and technical insight, supporting linguists to deliver translations that are not only precise but also compliant with global healthcare standards. At Avantpage Life Sciences, SMEs are the quiet but powerful champions ensuring that complex, regulated content reaches global audiences safely, clearly, and confidently. A subject matter expert is a professional with advanced knowledge in a specialised scientific field, such as, for example, pharmacology, biotechnology, clinical research, or medical device engineering. In life sciences translation, SMEs collaborate with linguists, project managers, and quality reviewers to interpret technical concepts, clarify context, and validate terminology.  While linguists master the target language, SMEs master the science behind the language. Together, they form a team that ensures the translation is scientifically sound, regulatory compliant, and linguistically precise.  For example, when translating a clinical trial protocol, an SME ensures that critical terminology (such as dosing schedules or endpoints) is correctly understood and translated. In the case of device labelling, the SME confirms that every instruction is medically accurate and aligned with safety regulations.  Life sciences content is full of complex terminology and strict regulatory language. From pharmacovigilance reports to patient-information leaflets, accuracy is non-negotiable. SMEs validate scientific terms, abbreviations, and compliance-related wording to ensure that each translated document meets the expectations of authorities such as the EMA, FDA or MHRA.  This alignment between language and regulation reduces risk and builds confidence that translations are ready for submission, publication or market release.  Even experienced translators can encounter ambiguous scientific phrases or emerging technical concepts. SMEs provide the background knowledge and domain understanding that help linguists interpret such challenges accurately.  For example, a single term like culture medium might have a distinct meaning in microbiology compared with biotechnology. The SME ensures the right contextual interpretation every time, enabling linguists to maintain precision and consistency.  Across multiple markets, products and regulatory documents, maintaining consistent terminology is essential. SMEs help build and refine term bases and glossaries that serve as shared reference tools for linguists, editors and clients.  This process ensures that translations remain uniform across all deliverables — from labelling and training manuals to e-learning modules and submissions — reinforcing brand integrity and compliance.  The life sciences industry leaves no room for error. A mistranslation could delay a product launch or cause confusion among healthcare professionals and patients. SMEs add an essential layer of review that protects against such risks, confirming that the scientific intent of the source text is preserved in every language.  By combining linguistic skill with subject expertise, the translation gains both clarity and credibility, two critical components of successful global communication.  When SMEs are involved early in a project, potential terminology or contextual issues can be identified before translation begins. This proactive approach prevents costly revisions, accelerates turnaround times, and ensures smoother collaboration between linguists, reviewers and clients.  At Avantpage Life Sciences, we integrate SMEs seamlessly into our translation workflows to guarantee scientific accuracy and regulatory compliance at every step.  Here’s how that partnership works in practice:  This structured life sciences translation workflow ensures that linguists and SMEs work as one cohesive unit, producing translations that are as clear as they are compliant.  The partnership between linguists and SMEs is built on mutual respect and collaboration. Linguists rely on SMEs for technical validation, while SMEs depend on linguists to ensure clarity and cultural fluency.  Together, they:  By combining linguistic skill and subject expertise, they transform technical information into communication that supports patient safety, research integrity and regulatory success.  In our sector, quality is defined by more than just linguistic correctness — it’s about trust. We know that life sciences clients operate in a world where a single mistranslation can delay approvals, impact safety, or undermine credibility. 

That’s why our translation processes are designed around collaboration between linguists, project managers and subject matter experts in life sciences translation.
Our translation projects benefit from:  Whether translating regulatory submissions, clinical documents, or patient materials, our SME-supported approach ensures accuracy, consistency and compliance across all markets.  Subject matter experts are the silent champions of life sciences translation. Their work happens behind the scenes, but its impact is visible in every compliant, accurate and trustworthy translation that reaches healthcare professionals, regulators and patients worldwide.  By supporting linguists with scientific insight and contextual clarity, SMEs transform the translation process into a partnership; one that ensures each word upholds the integrity of the science it represents.  At Avantpage Life Sciences, we believe that collaboration between linguists and subject matter experts is the foundation of translation excellence.  Ready to achieve greater accuracy and compliance in your life sciences translations? 
Discover how our SME-supported workflows can help your organisation communicate with confidence. Let's start the conversation!  

Each October, Breast Cancer Awareness Month unites people across the world in a shared mission: to promote early detection, innovation, and access to care. Yet, true awareness goes beyond pink ribbons and campaigns. It means ensuring that every individual, regardless of language or background, can understand and access essential health information.  That’s why breast cancer awareness in life sciences plays such a vital role. When scientific discovery, translation, and accessibility come together, awareness becomes equitable and care becomes truly global. According to the World Health Organization (WHO), breast cancer is one of the most common cancers worldwide, with approximately 2.3 million new diagnoses and 670,000 deaths annually. Projections suggest that by 2050, new cases could rise to 3.2 million per year, with deaths increasing to 1.1 million annually, disproportionately affecting countries with lower Human Development Index (HDI) scores. These figures highlight that early detection and access to understandable, culturally relevant health information are critical for improving outcomes and reducing disparities globally.  This year’s campaign theme, “Every Story Is Unique, Every Journey Matters", underlines the need for personal, inclusive communication. Patients who understand their condition and care pathway are more likely to seek help early, adhere to treatment, and feel empowered in their healthcare journey (WHO Advocacy Toolkit, 2025).  Yet millions face barriers due to limited health literacy, language differences, and cultural misunderstandings. Integrating translation and accessibility into every stage of the healthcare experience is crucial to advancing breast cancer awareness in life sciences.  Before breast cancer awareness can translate into action, it’s important to recognise the obstacles that prevent information from reaching everyone equally. These challenges span language, culture, literacy, and technology, and understanding them is the first step toward truly inclusive communication. Addressing these barriers requires collaboration between life sciences organisations, translators, and public health experts to ensure that awareness is accessible, accurate, and culturally appropriate.  By combining research, technology, and communication to improve health equity, the life sciences sector is uniquely positioned to break down these barriers.  Translation bridges the gap between research and real life. In breast cancer communication, accurate, localised translation helps ensure that patients, caregivers, and clinicians understand vital information: from diagnostic instructions to treatment options.  High-quality medical translation improves compliance, reduces anxiety, and empowers patients to make informed decisions about their health.  Digital health tools, mobile apps, and AI-driven diagnostics are expanding screening access. Yet, their impact depends on accessibility. Interfaces, instructions, and alerts must be translated and localised for global users.  Innovations like “Breamy”, an augmented reality app that helps visualise treatment outcomes, show how technology and communication together improve engagement (arXiv study).  When these tools are multilingual and culturally adapted, they can transform breast cancer care.  Clinical trials are the foundation of innovation in oncology. But many underrepresented populations remain excluded because study materials, consent forms, and recruitment materials are only available in a few languages.  By investing in life sciences translation and inclusive patient engagement, researchers can improve recruitment diversity and ensure that results represent global populations.  Trust is built on understanding. Translating clinical and educational materials into clear, patient-friendly language increases adherence and fosters open dialogue between patients and providers.  This is particularly important in oncology, where treatment plans are complex and emotionally charged. Accessible communication ensures that awareness leads to action, and ultimately, to better outcomes.  Raising awareness effectively requires thoughtful action and inclusive communication strategies. By taking deliberate steps, organisations can ensure that critical information reaches diverse communities and inspires meaningful engagement.  At Avantpage Life Sciences, we believe that medical innovation must go hand in hand with communication equity. We help organisations make this a reality by combining linguistic expertise with life sciences innovation to ensure healthcare and scientific content is understandable, accurate, and accessible in every language, communicated clearly, inclusively, and compassionately.  Through these capabilities, we help clients raise awareness across borders and barriers, advancing breast cancer awareness in life sciences with empathy and precision.  Breast Cancer Awareness Month is not only a global campaign, but also a reminder that awareness without accessibility leaves people behind. The future of healthcare depends on bridging the gap between innovation and understanding.  By combining translation, technology, and compassion, the life sciences industry can ensure that every person — regardless of language, culture, or geography — has equal access to life-saving information.  At Avantpage Life Sciences, we’re proud to help clients make their communication truly inclusive. If your organisation is developing oncology research, digital tools, or global awareness campaigns, we’d love to collaborate.  Get in touch to explore how translation and innovation can work together to advance health equity worldwide. 

When you’re looking for a language service provider to translate your content into a language you’re not familiar with, it can be hard to gauge translation vendor quality.  After all, if you’re not a trained linguist who’s literate in the target language, you won’t be able to analyze the final product for linguistic or style errors. And you’ll probably have an even harder time comparing the final translation of one vendor with that of another vendor. Clients seek out language service providers to do what they can’t: translate content from the language they speak into a language they don’t speak. But even if you can’t speak the target language, there are still ways to check the quality of your final product—you don’t have to blindly assume that one vendor is the best one for your project simply because they’re more familiar with the target language than you are. Though it may be difficult—especially if you’re new to purchasing language services—you can indeed evaluate translation vendor quality using means other than language knowledge. Here, we’ve identified seven ways that clients can evaluate the quality of translations you’ve commissioned from a language service provider. If you’ve identified a handful of different translation vendors that you could potentially work with, one way to sort out high quality vendors is to ask about the steps of their translation process. Each provider has their own way of doing things. Typically, they’ll start with a basic translation—either conducted by a human translator, a machine translation tool or both. Many providers will follow this with an editing step, and even a proofreading step (this process is typically referred to as TEP, short for “translation, editing, and proofreading”). To make sure that you’re avoiding any misspellings and stylistic or cultural errors, these last two steps are especially important ways to assure a high-quality translation. Be sure to ask what steps are included in the agency’s standard pricing and what are add-ons. There may be additional steps offered at a slightly higher price point, so keep these things in mind as you compare vendors. Did you know: At Avantpage, we use the traditional TEP process, but have added two additional quality check steps at no added cost. Like many other industries, the language services industry has several certifying bodies that evaluate a company’s overall quality. When researching language service providers, check if they advertise their certifications on their website. The American Translators’ Association is well-recognized for their certifications of individual translators and linguists, while the International Organization for Standardization (ISO) has several certifications relevant to the language industry, such as ISO 17100 Translation Services and ISO 9001 Quality Systems Management. Did you know: Avantpage is certified in both the ISO 17100 Translation Services and ISO 9001 Quality Systems Management.  You’ll also want to ask your vendor about their internal quality assurance processes. By doing so, you’ll be able to ensure they have some set of systems in place to maintain translation quality. To start this conversation, you can ask the provider if they have an internally dedicated QA team. If they do, ask them how big the team is and what each person does.  A well-structured QA department indicates that the vendor has a robust system of checks and balances, reducing the likelihood of errors in your translations. Additionally, vendors with internal QA teams, especially those with in-house language experts, may offer cost savings compared to those relying on external freelancers. This level of detail reflects the vendor’s commitment to consistent, high-quality work. Did you know: Avantpage has a dedicated QA department, with on-staff linguistic reviewers to manage quality control and pass savings on to you. Reviews from other clients can provide valuable insights into a vendor’s quality and reliability. Look for feedback on key factors like translation accuracy, adherence to deadlines, communication, and overall satisfaction. Pay extra close attention to reviews or quotes from clients in similar industries to yours, especially if they have similar project types, as their experiences will be more relevant to your needs. If possible, reach out to past clients directly for more detailed feedback. Consistent positive reviews and high client retention rates are strong indicators that a vendor delivers dependable, high-quality work across projects. Did you know: Avantpage shares regular client quotes on our LinkedIn page and on our client website page to help you see what our clients say about us. Language service providers that work in highly regulated industries such as government, life sciences, and healthcare, often have to complete audits for their clients. In doing this work, language service providers are able to document the quality of their work for clients that must comply with the strict regulations of their industry. By asking about their history of audit compliance, you can get a better feel for the provider’s commitment to quality—strong compliance with audits may be indicative of a higher-than-average level of quality. Did you know: Avantpage works annually with many clients to conduct compliance audits so they can adequately meet and report to overseeing organizations. Look into how long your potential providers have been working in the language service industry. The longer a company’s been around, the more likely they are to have established themselves as a high-quality provider. Additionally, look at the different lineup of clients they’ve worked with—if they’ve worked with high-profile clients in your industry (and maintained a long working relationship with them), they’re likely to be a good fit for your needs. Many agencies will provide case studies on their website or on request—these can provide you with valuable information about their clients and their professional relationships. If one case study strikes you as particularly interesting, you can also ask the vendor for more information about it to learn a bit more. You may also like: our Avantpage Case Studies page showcases the work our partners do to meet language access. Lastly, you’ll want to ask what additional checks and balances the vendor uses to maintain their translation quality. Ask them if they conduct regular quality tests on translations, as well as design and formatting if they’re relevant to your project. If they do, be sure to ask how often they conduct these checks, as well as how thorough these tests are. These tests can come in many different forms: internal assessments, surveys of project-level satisfaction, annual customer surveys, and more. Language service providers with structured processes for internal quality review and testing are more likely to demonstrate a commitment to accountability and continuous improvement. When you work with a vendor that employs a thorough set of checks and balances, you can rest easy knowing that quality is a top priority for them, as these measures help ensure that translations meet a consistent standard of quality, regardless of the project size or complexity. Did you know: Avantpage conducts regular surveys to get feedback from clients, and we have rigorous quality testing thresholds to hold ourselves accountable.  When you’re looking for language service providers to help you out with your next translation project, be sure to ask questions and do your research to make sure you’re getting the best quality possible. Though it can be a daunting task to evaluate a provider’s quality—especially if you’re not familiar with the target language—there are several steps a layperson can follow to assess a translation agency’s quality.  Here are seven that we’ve identified to help you out on your search: If you’re looking for a high-quality language service provider to help you out with your next translation project, Avantpage Life Sciences has you covered. We’ve got more than two decades of experience providing translations to clients across a wide range of regulated industries—contact us today at [email protected] or submit an enquiry to learn more.